An observational study in Atrial Fibrillation and Arterial Hypertension, sponsored by Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health. Completed at 1 site in Russian Federation. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2021-01-27.
Sponsored by Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · Observational
The Clinical Decision Support Systems (CDSS) based on real clinical data and its own algorithms can help to make the right choice. This trial is designed to assess the difference between retrospective electronic medical cards (EMC) therapy prescriptions and MedicBK prescriptions based on key patient characteristics.
There is a lot of data from registries about poor adherence to guidelines. It is connected with a problem that patients usually have a lot of comorbidities and physicians need to know сonsequently the huge number of medications and combinations. It is very difficult to decide quickly according to available data from libraries like PubMed. The Clinical Decision Support Systems (CDSS) based on real clinical data and its own Artificial Intelligence algorithms can help to make the right choice. This trial is designed to assess the difference between retrospective electronic medical cards (EMC) therapy prescriptions and MedicBK prescriptions based on key patient characteristics.
Two groups of experts (cardiologists with clinical practice for more than 5 years) will be participating in the trial.
Using main characteristics from EMC the first group of experts will put this data into MedicBK platform and assess retrospective treatment. The next blinded group of experts will perform prescriptions using MedicBK algorithms based on current guidelines and data from available clinical trials. The main hypothesis is the use Clinical Decision Support Systems (CDSS) better than current clinical practice. This option can help to make the right choice of medical combination based on main patient's clinical characteristics
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 191 is close to the median of 210 across 1,359 observational studies indexed under Hypertension.
Browse Hypertension studies →Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health is the lead sponsor of 30 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with nonvalvular atrial fibrillation and essential hypertension having indications for therapy according to European guidelines
Exclusion Criteria:
retrospective data on treatment from EMC
Drug: Retrospective analysis of assigned treatment
Treatment assignment using medicBC CDSS platform in the same cohort of patients
analysis of treatment assigned by physicians within routine clinical practice
Assessment of AF/AH treatment guidelines compliance
Number of electronic medical records not compliant to the AF/AH clinical practice guidelines
Time frame: 1 MONTH
Assessment of MedicBK programme
Number of prescriptions from electronic medical records appropriate or inappropriate according to the AF/hypertension clinical practice guidelines in comparison with the treatment's choice of CDSS platform
Time frame: 1 MONTH
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health